Fundraising FoxLaerdal Million Lives Fund — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Avive develops automated external defibrillators (AEDs) and cardiac emergency response systems designed to improve outcomes for sudden cardiac arrest.
Digital HealthHealthtechIoTMedical DevicesForsyth, US
Rory Beyer(President / Chief Operating Officer, Co-Founder)inMoseley Andrews(Co-Founder)inSameer Jafri(Chief Executive Officer, Co-Founder)in
Co-investorsAngel Physicians FundCatalyst Health VenturesEckuityHealthtech CapitalIrishAngelsQuesta Capital+2 more
Boulder provides medication-assisted treatment for addiction through licensed specialists who prescribe buprenorphine, supported by dedicated care teams offering medical care, peer recovery coaching, and care coordination accessible via a digital platform.
Digital HealthHealthtechMental HealthBoulder, US
Stephanie Papes(Cofounder)Stephanie Strong(Founder)Jordan Nof(Director)Frank Ingari(Director)Josh Kopelman(Director)
Co-investorsAdvance Venture PartnersAlumni VenturesFirst Round CapitalGaingelsGreycroftQiming Venture Partners USA+5 more
__Twitter.png)
Connected is a web-based address book that consolidates a user's contacts from email accounts and social networks into a single view.
Media & Entertainment
Sachin Rekhi
Co-investors500 GlobalFocus Central AmericaCatalyst Health VenturesEckuityQuesta CapitalRC Capital
Novocuff is a medical device company developing the Novocuff Cervical Control System, an investigational device aimed at improving outcomes for pregnancies affected by preterm prelabor rupture of membranes (PPROM) or cervical shortening.
FemTechHealthtechMedical DevicesMountain View, US
Donald Lee(Executive Officer)inAmelia Degenkolb(Executive Officer, Director)in
BoardLilly DeSouza Burr(Director)Curt LaBelle(Director)Rebecca Shmukler(Director)inShacey Petrovic(Director)in
Co-investorsAvestria VenturesForeground CapitalGlobal Health Investment FundTullis Health Investors
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.